Baird Medical Investment Holdings Ltd

BDMDdata completeness 100%4 fiscal years on file
i. The business — what you’d actually own
FigureFY 2022FY 2023FY 2024FY 2025
Revenue$35.1M1$31.5M2$37M2$22.5M2
Net income$12.8M3$10.5M4$12.5M4−$27.3M4
Operating cash flow$485,9685−$1.02M6−$6.31M6−$1.34M6
Capital expenditure$5.91M7$2.64M8$2.85M8$42,3158
Free cash flow (derived)−$5.42M5−$3.66M6−$9.17M6−$1.39M6
Total debt$2.43M9$8.76M10$17.4M10
Cash & equivalents$1.71M11$1.51M11$2.97M12$178,32112
Diluted shares25.6M20.6M21.8M27.8M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
You’d own
0.000036%
of the whole company
Your share of last year’s profit
−$9.81
Your share of its debt
$6.28
Your share of free cash flow
−$0.5
iii. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
$4.36
assumptions (8)
  • riskFreeRate4.5%
  • equityRiskPremium5.0%
  • beta100.0%
  • equityWeight85.0%
  • costOfDebtSpread1.5%
  • taxRate21.0%
  • normalizedEarnings$11.5M
  • growthAssumed0.0%
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (ProfitLoss)
  4. 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (NetIncomeLoss)
  5. 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (NetCashProvidedByUsedInOperatingActivities)
  6. 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (NetCashProvidedByUsedInOperatingActivities)
  7. 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (PaymentsToAcquirePropertyPlantAndEquipment)
  8. 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (PaymentsToAcquirePropertyPlantAndEquipment)
  9. 20-F · period ending 2023-12-31 · accession 0001410578-25-001328 (LongTermDebtNoncurrent)
  10. 20-F · period ending 2024-12-31 · accession 0001104659-26-048641 (LongTermDebtNoncurrent)
  11. 20-F · period ending 2022-12-31 · accession 0001104659-26-048641 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)
  12. 20-F · period ending 2024-12-31 · accession 0001104659-26-048641 (CashAndCashEquivalentsAtCarryingValue)